The molecular coupling of CAS and Crk in response to integrin activation is an evolutionary conserved signaling module that controls cell proliferation, survival and migration. However, when deregulated, CAS/Crk signaling also contributes to cancer progression and developmental defects in humans. Here we highlight recent advances in our understanding of how CAS/Crk complexes assemble in cells to modulate the actin cytoskeleton, and the molecular mechanisms that regulate this process. We discuss in detail the spatiotemporal dynamics of CAS/Crk assembly and how this scaffold recruits specific effector proteins that couple integrin signaling networks to the migration machinery of cells. We also highlight the importance of CAS/Crk signaling in the dual regulation of cell migration and survival mechanisms that operate in invasive cells during development and pathological conditions associated with cancer metastasis. D
Introduction
Integrins are a large family of transmembrane receptors that not only facilitate cell adhesion to proteins in the extracellular space, but also transmit signals to control numerous biological processes including cell proliferation, survival and migration [1, 2] . Of the numerous signals emanating from integrin receptors, tyrosine phosphorylation of the docking protein p130CAS (Crk-associated substrate, CAS) and its recruitment and binding of the adaptor protein c-CrkII (CT10 regulator of kinase, Crk) have proven to be a critical response in controlling integrin-dependent processes. Indeed, research over the past years indicates that assembly of this molecular signaling scaffold plays a critical role in organization of the actin cytoskeleton leading to cell migration [3, 4] , invasion [5, 6] , phagocytosis [7] and survival [5, 8] . Furthermore, Crk and its effector proteins are evolutionarily conserved and serve similarly important functions in eukaryotic development. In C. elegans, genes regulating cell engulfment and cell migration (ced-2, ced-5, ced-10 and ced-12) encode for homologous proteins to the mammalian c-CrkII, DOCK180, Rac1 and ELMO1, respectively [9, 10] (Fig. 1) . However, deregulation of Crk function in adult organisms may contribute to the progression of cancer and human disease [11] . In this review, we present what is known about the molecular mechanisms that control the assembly of CAS/Crk and its effectors, and we discuss the recent advances in our understanding of how these processes are spatiotemporally regulated to control cell migration and survival under normal and pathological states associated with cancer progression.
CAS and Crk family members
The Crk family adaptors (c-CrkI, c-CrkII, c-CrkIII, CrkL, v-Crk) are comprised of Src Homology 2 (SH2) and Src Homology 3 (SH3) domains ( Fig. 2A ) that serve to assemble macromolecular protein complexes and target them to distinct regions within the cell [12 -14] . Surprisingly, despite the lack of any kinase domain, the retroviral-encoded oncogene v-Crk can initiate transformation of chicken fibroblasts and induce tumors in animals [15] . Since the presence of CrkSH2 and CrkSH3 domains alone can trigger 0167 oncogenic transformation as well as normal cellular responses, it has been the focus of many studies to identify the effector proteins that selectively bind to these domains and to understand how they transmit intracellular signals to specifically control various biological processes (for recent reviews, see Refs. [16 -18] ).
The c-crk gene encodes three alternatively spliced translation products: c-CrkI, c-CrkII (hereafter referred to as Crk), and the recently identified c-CrkIII [19] . While the mammalian Crk family members share similar overall structure, the biological differences between each member is not entirely clear. c-CrkII is a 42-kDa protein consisting of one SH2 and two SH3 domains, CrkSH3(1) and CrkSH3 (2) . The SH3 domains are separated by a spacer region that contains a critical negative regulatory tyrosine at residue 221 (Y221). Upon phosphorylation of this residue, Crk undergoes an intramolecular folding response in which its own SH2 domain interacts with Y221 [20, 21] . This prevents binding of Crk to tyrosine-phosphorylated proteins including CAS, and inhibits the binding of effectors to its SH3(1) domain. c-CrkI was found to have 60% sequence homology to c-CrkII and differ in sequence primarily with the absence of the second SH3 domain [22] . Also, c-CrkI does not contain the Y221 negative regulatory site and immunoprecipitates with increased levels of tyrosine-phosphorylated proteins, when compared to c-CrkII [6] . Furthermore, while CrkL contains a similar tyrosine residue to Y221 at position 207 (Y207), there is no evidence available to suggest that this site regulates intramolecular folding similar to c-CrkII. The preferred binding motif for CrkSH2 domains predominantly contains a phosphorylated tyrosine residue followed by a proline in position + 3 [23] . The specific binding proteins which contain multiple pTyr-x-xPro sequences and associate with the SH2 domain of Crk include paxillin [24 -27] , CAS [25,28 -30] , c-Cbl [31 -34] , STAT5 [35, 36] , Gab2 [37, 38] , PI3K [39, 40] and SHIP [41 -43] (Fig. 3) . Alternatively, the selective CrkSH3(1) domain typically binds to proline-rich motifs with the consensus sequence of Pro-x-x-Pro-x-Lys [44] , and recognizes proteins including C3G [45 -48] , DOCK180 [49, 50] , c-Abl [51 -55] , Sos [56] , Eps15 [57 -59] and JNK [60, 61] (Fig. 3) . On the other hand, the CrkSH3(2) domain shows a limited ability to interact with effector proteins, and to date has been demonstrated to only bind the nuclear export factor Crm1/ exportin [62] . The cloning and identification of c-CrkIII, which differs mainly from c-CrkII in its truncated Cterminal SH3 domain, may provide future insight into the unknown function of this particular domain [19] . Interestingly, in c-CrkIII the Crm1 binding site lies just outside the conserved CrkII sequence, and as a result, CrkIII lacks the ability to bind this nuclear export factor. This could explain observations by Prosser et al. indicating that CrkIII localizes to the nucleus of human mesangial cells, and certainly begs the query of the biological function of nuclear-localized cCrkIII [19] . Recent evidence also indicates that the CrkSH3(2) domain is necessary for Crk-mediated cell transformation, which suggests that additional effectors interact with this region of Crk [19] . CrkL, which has an overall similar structure to c-CrkII, is also composed of one SH2 and two SH3 domains and sequence comparison shows high homology to c-CrkII [63] . CrkL has been reported to be tyrosine-phosphorylated in patients with chronic myeloid leukemia (CML) and involved in integrin-mediated cell migration [22, 64, 65] . The CrkL SH2 domain appears to have the same specificity for pTyr-x-x-Pro motifs and associates with similar sets of proteins as c-CrkII in vitro, suggesting that in many cases these proteins share similar functions [22] . In this review, we focus primarily on the interactions between c-CrkII and CAS, and how these proteins control specific signaling events.
The CAS family now includes at least three distinct proteins in mammals and invertebrates that include the homologous Human enhancer of filamentation/Cas-Like (Hef1/CASL) and Embryonal fyn-associated substrate/Srcinteracting protein (Efs/Sin) [66 -68] (Fig. 2B) . The cloning of CAS cDNAs revealed a protein consisting of an aminoterminal SH3 domain, a substrate domain consisting of multiple SH2-domain binding motifs (Tyr-x-x-Pro), proline and serine-rich regions, and several tyrosine residues near the C-terminus [30, 68, 69] . The various domains within CAS enable it to interact with numerous cellular proteins (Fig. 3) , and CAS appears to function as a multi-site docking protein to recruit required binding partners following activation of specific signaling pathways. However, the regulation and function of many CAS/multi-protein complexes is still unclear. The Hef1/CASL and Efs/Sin family members share similar domain structure and sequence similarities with CAS (Fig. 2B) , with the most notable difference being in the absence of the proline-rich region in Hef1/CASL. While CAS family members contain structural similarity, they appear to have distinct differences in tissue expression and subcellular localization. The expression of CAS is observed in most adult tissues, while Hef1 mRNA expression is lower in the brain and liver and is observed primarily in lymphocytes [70, 71] , and the expression levels of Efs/Sin are greatest in embryonic tissues [67] . Within the cell, all three family members are largely cytoplasmic, but CAS and Hef1 have been shown to translocate to focal adhesion complexes following integrin activation [70, 72, 73] .
Integrin-mediated mechanisms of CAS/Crk coupling
The substrate domains of CAS proteins have been reported to be heavily tyrosine-phosphorylated upon integrin activation events [74, 75] , and the assembly of CAS with the SH2(1) domain of Crk is critically dependent on its phosphorylation state. Increased tyrosine phosphorylation of the CAS substrate domain is necessary for proper cell spreading and migration on various ECM proteins [76, 77] . However, the precise mechanism by which CAS is tyrosinephosphorylated by integrins is unclear due to the ability of CAS to interact with both the Src and focal adhesion kinase (FAK) families via its C-terminal and SH3 domains, respectively. The SH3 domain of CAS may regulate the phosphorylation of its substrate domain and subsequent downstream signaling events through recruitment of FAK [25, 78, 79] , as well as the proline-rich tyrosine kinase-2, Pyk2 [80, 81] , and the tyrosine phosphatases, PTP-PEST [82] and PTP-1B [83] . Additionally, the tyrosine residues at the C-terminus provide binding sites for the SH2 and SH3 domains of the Src family kinases [30, 69] , Grb2 [28] , PI3K [84] and several other proteins [28, 85] . Of the vast number of proteins which can assemble with CAS and Crk (Fig. 3) , many have typically been associated with organization of the actin cytoskeleton and the migration machinery of the cell [3, 74] .
While FAK and Src are good candidates as regulators of CAS phosphorylation, a major question remains as to what kinases phosphorylate CAS to promote CAS/Crk coupling. Coordinate phosphorylation of CAS and FAK has been observed during cell adhesion [74, 75, 86] and these proteins are colocalized in focal adhesion contacts [73] . FAK-promoted tyrosine phosphorylation of CAS has also been linked to cell migration [76, 77] . However, in FAK-null cells, some studies have reported no change in levels of phosphorylated CAS when compared to cells reexpressing FAK [87] , and CAS is a poor substrate of FAK in vitro [88] . The FAK-related kinase, Pyk2, has been reported to be upregulated in FAK-null cells and may compensate in lieu of FAK [81, 87] . Despite its apparent kinase function though, FAK has also been implicated to serve as a docking protein in recruiting and activating Src family kinases, which lead to CAS phosphorylation [88] . Src kinases have also been demonstrated to directly promote tyrosine phosphorylation of the substrate domain of CAS, as phosphorylated CAS in Src-null cells is significantly lower than control cells reconstituted with Src [73,89 -92] . Additionally, the phosphorylation of CAS on tyrosine 253 by Src has recently been demonstrated to be required for Src to augment cell migration, but not required for Src to enhance the effects of CAS on growth rate and anchorage independence [93] . Thus, it is likely that FAK and Src synergistically work together to phosphorylate the substrate domain of CAS in response to integrin ligation. However, it appears that future work is necessary to precisely determine how these tyrosine kinases function to regulate CAS/Crk assembly downstream of integrin activation.
Once tyrosine-phosphorylated, CAS manifests its downstream signaling primarily through its association with Crk and its associated effectors, and many studies have reported integrin-mediated CAS/Crk assembly [3,76,91,94 -97] . CAS/Crk complexes signal reactions that eventually result in the activation of Rac1 via a functional cooperation between the GTPase-activating protein DOCK180 and ELMO1, which serve to target Rac1 activation to discrete intracellular locations [49, 98, 99] . In addition to integrinmediated CAS/Crk signaling, many growth factors have been reported to induce rearrangements of the actin cytoskeleton concomitant with increased levels of CAS tyrosine phosphorylation and subsequent CAS/Crk coupling [5, 39, 45, 76] . Upon stimulation with epidermal growth factor (EGF), platelet-derived growth factor (PDGF) or insulin, cells exhibit rapid cytoskeleton rearrangement initiated through a phosphatidylinositol 3V-kinase (PI3K)-dependent activation of Rac1 [100 -102] . Furthermore, following EGF and PDGF stimulation, CAS phosphorylation was observed to exhibit a bell-shaped dose -response curve, which required PI3K catalytic activity [103, 104] , and low concentrations of EGF stimulated the formation of CAS/Crk complexes [103] . These data suggest that CAS/Crk could participate in growth factor signaling, possibly involving cross-talk between integrin-mediated activation events involving FAK and Src family kinases. Other growth factors/ chemokines have also been reported to promote CAS phosphorylation, suggesting that numerous growth and motility signals may operate through CAS/Crk coupling and its upstream regulators [39, 45] .
In contrast to the positive regulation of CAS/Crk assembly discussed above, several effector proteins have been reported to negatively regulate CAS/Crk coupling. For example, c-Abl phosphorylates Crk at tyrosine Y221 resulting in the decoupling of CAS/Crk complexes and the interruption of cell migration [5, 8] . On the other hand, dephosphorylation of Crk-Y221 by PTP-1B promotes increased CAS/Crk coupling and cell migration [4] . Also, cells expressing activated PTP-PEST exhibited defective migration that was paralleled with a decrease in levels of tyrosine-phosphorylated CAS [94, 105] . In addition to an uncoupling of CAS/Crk complexes, reports have indicated cleavage of CAS by caspase-3 to coincide with a delocalization of FAK from sites of focal contacts [106] . The decoupling of CAS/Crk complexes and the cleavage of CAS are observed events during apoptosis, and accordingly, disruptions in CAS/Crk signaling appear to prevent the transmission of survival signals from the cytoskeleton (discussed below).
Taken together, the phosphorylation states of CAS and Crk appear to be critical in selectively activating distinct signaling pathways that determine the fate of a cell, such as migration or apoptosis. The future challenge will be to sort out which posttranslational modifications are necessary for CAS/Crk signaling, and when, where and how these modifications coordinately cooperate with other effectors to dynamically regulate the processes involved in cell function.
Spatiotemporal regulation of CAS/Crk assembly/ disassembly
While the spatial and temporal assembly of CAS and Crk is not understood, recent evidence has shed some insight into this process. In suspended cells, Crk is primarily limited to the cytoplasm, whereas upon cell attachment and integrin activation, Crk becomes tyrosine-phosphorylated at residue Y221 and translocates to the plasma membrane. The expression of a Crk tyrosine 221 to phenylalanine mutation (CrkII-Y221F) caused Crk to be retained in the cytoplasm, preventing its localization to the membrane [117] , and interestingly, Rac also failed to translocate to the membrane and induce membrane ruffles and cell migration. Even the coexpression of constitutively active Rac (RacV12) failed to localize to the membrane in these cells [117] . However, this apparent loss of Rac signaling and motility could be overcome by targeting RacV12 or CrkII-Y221F to the membrane with a myristylation sequence, suggesting that Crk mediates Rac translocation to the membrane.
A genetically encoded fluorescent resonance energy transfer (FRET) indicator that directly reports Crk-Y221 phosphorylation in living cells showed strong Crk-Y221 phosphorylation in membrane ruffles [118] . In this report, PDGF stimulation of cells revealed a pattern of Crk phosphorylation that began in the cytoplasm surrounding the perinuclear region of the cell body and emanated outward to membrane ruffles in the extending lamellipodium. Similarly, early work using immunofluorescence and phosphospecific antibodies to the Crk-Y221 site also revealed a significant level of phosphorylated Crk in membrane ruffles [119] . Interestingly, in CrkII-Y221F mutated cells, the FRET reporter did not localize to membrane ruffles and no FRET activity was observed in the membrane (R.L. Klemke and K.H. Kain, unpublished data). Based on these studies, it appears that Crk phosphorylation first occurs in the cytoplasm and then rapidly moves to peripheral membrane ruffles in stimulated cells. Although the mechanism of translocation is not known, apparently it does not require functional SH2 and SH3 domains as phosphorylated Crk would be expected to be in an inactive folded conformation unavailable to associate with its binding partners. Alternatively, the SH2 domain of Crk contains a polyproline sequence (PPPP) that is exposed upon binding to phosphotyrosine residues including its own Y221 [21] . This raises an intriguing possibility that the PPPP motif of Crk binds to the SH3 domain of a shuttle protein that transports phosphoCrk to the membrane. As discussed below, Abl tyrosine kinase is a possible candidate as it phosphorylates Crk-Y221 and can interact with the PPPP region through its SH3 domain [21] . In any case, the tyrosine phosphorylation of Crk at Y221 is a critical event for intracellular translocation of Crk and Rac from the cytoplasm to the membrane in response to integrin and/or growth factor receptor ligation.
Upon translocation to the membrane, how does Crk associate with CAS and regulate Rac activity? In the simplest case, Crk phosphorylation induces translocation to membrane ruffles, where it is rapidly deposphorylated by a phosphatase like protein tyrosine phosphatase-1B (PTP-1B) [4] (Fig. 4) , and dephosphorylated Crk is then available to couple to its downstream effector proteins. Tyrosinephosphorylated CAS has been shown to localize to the extending lamellipodia of migrating cells and CAS/Crk complexes are highly enriched in purified lamellipodia structures [76, 92, 120] . The localized CAS/Crk complexes then recruit DOCK180 and Rac leading to GTPase activation, actin dynamics and cell migration (Fig. 4) . However, this may not always be the case, as more recent evidence indicates that integrin activation promotes dephosphorylation of Crk-Y221 through activation of PTP-1B, resulting in increased CAS/Crk complexes and motility [4] . It was also shown in this study that expression of Crk-Y221F in cells increased CAS/Crk coupling and migration. The discrepancy in these reports may be due to different cell types and expression levels of Crk-Y221F utilized by these groups. However, in either case, these studies illustrate the importance of Crk-Y221 phosphorylation in the regulation of cell migration and point to the need for additional studies to clarify the role of integrins in modulating this process in time and space.
While CAS/Crk/Rac localize to membrane ruffles and these proteins are necessary for cell migration, there is also compelling evidence that this signaling module localizes to focal adhesions. Using antibodies directed against phosphorylated YxxP tyrosines of the CAS substrate domain, tyrosine-phosphorylated CAS has been shown to localize to newly forming focal adhesions in extending lamellipodia as well as mature focal adhesions underlying the cell body of migrating cells [92] . Additionally, CAS has been shown to function in recruiting Crk to focal adhesions [91, 121] , and Crk, in turn, recruits DOCK180 to these structures [98] . The assembly of a CAS/Crk/DOCK180 scaffold at focal adhesions could drive localized Rac activity leading to actin polymerization and recruitment of high-affinity integrin receptors necessary for lamellipodium extension and cell migration [122] . In support of this, forced targeting of CrkL to focal adhesions has been shown to be sufficient to recruit DOCK180 to these structures and to induce Rac and Cdc42 activity leading to cell migration [64] . It is important to note that the initial protrusion of a lamellipodial membrane away from the cell body does not require integrin-dependent signaling events, as cells display random membrane protrusion as well as directional extension towards chemokine gradients independent of the ECM [123, 124] . This places the initial Rac activation upstream of ECM-driven integrin signaling processes. However, as a lamellipodium extends, it must attach to the ECM, otherwise it rapidly retracts back to the cell body [124 -126] . Therefore, integrin ligation events at the front of the lamellipodium provide positive feedback signals to maintain Rac activity, which leads to a persistent and directional membrane protrusion. Loss of ECM substrate contacts would turn off the positive feedback signal provided by Rac, preventing further lamellipodial extension. In this manner, integrins serve to regulate lamellipodial dynamics and fine-tune directionality during cell migration. Indeed, biochemical purification of lamellipodia in either the growth or retraction phase revealed the dynamic coupling/uncoupling of CAS/Crk complexes and Rac activation, respectively [120] . In this study, forced CAS/Crk coupling was found to maintain lamellipodia extension and prevent membrane deadhesion and retraction from the substratum. Furthermore, persistent Rac activation in cells promoted sustained CAS/Crk coupling and prevented lamellipodium retraction, supporting the notion that this signaling pathway serves as a positive feedback mechanism for controlling membrane dynamics [120] . Thus, during cell migration, integrin-mediated attachment of the lamellipodium to the supporting ECM is critical not only for the generation of traction force (Ref. [127] and references therein), but also for signal transduction processes that stabilize and fine-tune the direction of the extending membrane as it navigates the ECM. On the other hand, Rho activation appears to play a necessary role in lamellipodium retraction [123] .
A key question remains as to how the CAS/Crk/ DOCK180 scaffold assembles/disassembles within the specialized lamellipodial compartment. Surprisingly, biochemical examination of lamellipodia under growth and retraction conditions revealed that Crk uncouples from CAS without apparent changes in FAK activity and CAS tyrosine phosphorylation [5, 123] . In this case, uncoupling may occur via dephosphorylation of only a subset of the specific Try-x-x-P motifs, which interact with the SH2 domain of Crk, and not through global dephosphorylation of CAS. It will be necessary to map the specific tyrosine sites in the CAS substrate domain and determine which one(s) are regulated in migrating cells. Furthermore, although Crk phosphorylation at Y221 has been shown to prevent CAS/Crk coupling, it is unlikely that this is the primary mechanism used by the lamellipodium to uncouple this scaffold, as the pool of phosphorylated Crk-Y221 remains relatively unchanged in growing and retracting lamellipodia (R.L. Klemke and D. Chodniewicz, unpublished data). Therefore, it seems more likely that a tyrosine phosphatase, such as PTP-PEST or PTP-1B, targets dephosphorylation of specific Crk-binding motifs within the CAS substrate domain [94, 105] . While progress has been made in understanding the biochemistry of CAS/Crk coupling, identification of the precise location and time that this process occurs within the cell will require development of novel FRET reporters and phosphospecific antibodies against regulatory residues on CAS [92] and Crk. Such highresolution tools will undoubtedly uncover novel spatiotemporal information about the organization of this signaling module within dynamic, motile cells.
Abl family kinases are key regulators of CAS/Crk assembly
The Abl family includes c-Abl and the c-Abl-related gene, arg (for recent review, see Ref. [128] ). These enzymes are highly homologous, being comprised of SH2, SH3, actin binding, polyproline and tyrosine kinase domains [129] . While their similar domain structure strongly suggests that they may function redundantly [54, 128] , there are notable differences including the ability of c-Abl to shuttle between the nucleus and cytoplasm, due to its nuclear localization sequences which are absent from the arg gene product [130] . Furthermore, approximately 75% of abl À / À animals die postpartum, and although viable, the surviving mice exhibit behavioral defects including thymic atrophy, lymphopenia, osteoporosis, improper eye development and spermatogenesis [131] . When both the abl and arg genes are deleted, animals die early in development (E9 -11) from neurological defects [132] .
The molecular mechanism by which Abl and Arg are spatially and temporally regulated is multi-faceted, as these enzymes are dynamically controlled by diverse extracellular factors including integrins, growth factors and apoptotic agents [131, 133] . Interestingly, upon integrin ligation or cytokine exposure, Abl/Arg are reported to be activated and localize to areas of CAS/Crk assembly including focal adhesions and membrane ruffles [55, 110, 134, 135] . This and the fact that both Abl and Arg interact with the SH3 domain of Crk via their conserved polyproline region, and promote tyrosine phosphorylation of Crk-Y221 [8, 109, 136] , set the stage for recent work demonstrating an important biological role for Abl family kinases in the regulation of CAS/Crk coupling in cell migration [51, 130] as well as apoptosis (discussed below). These studies demonstrated that a kinase dead form of Abl or exposure of cells to the Abl kinase inhibitor STI 571 enhanced CAS/Crk coupling and cell migration by decreasing phosphorylation of Crk-Y221 [137] . Conversely, expression of a constitutively activated form of Abl prevented the assembly of CAS/Crk complexes and inhibited cell migration, which was dependent upon a functional PPPP domain and Crk-Y221 phosphorylation [8, 136, 137] . Examination of this signaling pathway in embryonic fibroblast cells isolated from abl À / À arg À / À deficient mice [132] revealed a complete loss of basal Crk-Y221 phosphorylation. These cells also exhibited increased CAS/Crk coupling and cell migration, and reconstitution of these cells with Abl reversed this response. A similar Abl-dependent pathway may also exist to regulate HGF-induced motility, as cells exposed to STI 571 showed enhanced cell migration in response to this growth factor [138] , and Crk is known to play an important role in mediating HGF-induced cell migration [139] . However, in the case of PDGF signaling, Abl activity may play a positive role by increasing chemotactic motility via downregulation of phospholipase C-g1 (PLC-g1) activity. How this signaling process couples to the migration machinery is not known, but must be different from previous work that demonstrated a positive role for PLC-g1 activity in cell motility [140, 141] .
A central question remains as to how integrins regulate Abl/Arg activity to negatively modulate CAS/Crk coupling and cell migration, especially in light of the fact that integrin ligation is known to promote activation and translocation of Abl from the nucleus to focal adhesions [135] . One possibility is that integrin-mediated Abl activation serves as a negative feedback pathway to control the level of CAS/Crk coupling through direct phosphorylation of Crk-Y221. This would effectively reduce the pool of active Crk available to interact with phosphorylated CAS following integrin activation. Such a negative feedback signal would be expected to operate transiently downstream of integrins to bring about steady state levels of CAS/Crk complexes in cells, as is the case with Abl [8, 135, 137, 142] . Also, the increased association of Abl with the SH3 domain of Crk may displace positive effectors like DOCK180 that facilitate cell migration, which would reinforce the negative inhibition of cell migration by Abl. Interestingly, Abl phosphorylation and the molecular folding of Crk has been shown to unmask a PPPP motif in Crk that can further interact with the SH3 domain of Abl, providing increased molecular stability to this protein complex. The Abl/Crk complexes would then be in position to outcompete positive effectors for binding to the SH3 domain of Crk [17, 21] . Also, mutations in the CrkSH3(2) domain and linker region have been shown to increase Abl binding to the CrkSH3(1) domain, suggesting an additional mechanism for regulation of Abl/Crk formation [143] .
The dynamic nature of Abl, along with its ability to both phosphorylate and tightly bind Crk, suggests that this enzyme could also serve as a shuttle protein to deliver phosphorylated Crk to the membrane and/or focal adhesions [3, 144] (Fig. 4) . In this case, integrin-induced signals would induce formation of Abl/Crk complexes and their translocation to the membrane and/or sites of focal adhesions. Abl would then retain inactive Crk in these structures until dephosphorylation of Crk-Y221 occurs by a tyrosine phosphatase resulting in the disassociation of Abl, leaving Crk free to interact with other proteins like CAS and DOCK180 (Fig. 4) . Under these conditions, integrin-mediated activation of Abl would provide a sensitive mechanism to modulate the pool of active/inactive Crk available to bind effectors in distinct compartments of the cell. However, while this model is supported by evidence that Crk-Y221 phosphorylation is necessary for Crk translocation, Rac activation and motility [117] , it does not explain why cells migrate better in the complete absence of Abl and Arg proteins or when Abl kinase activity is blocked with STI 571 [8, 137, 138] . This seems conflicting with the speculative function of Abl as a transporter of Y221-phosphorylated Crk to the membrane, as well as the requirement for Crk-Y221 phosphorylation in Rac-dependent signaling events and motility [3, 145] . It is possible that abl À / À arg À / À cells utilize a different tyrosine kinase to phosphorylate and target Crk to critical regions in the cell, or utilize a Crk-independent mechanism altogether to regulate Rac translocation and activation. Abl has been shown to regulate actin-mediated microspike formation independent of the Rho-family GTPases [146] . However, abl À / À arg À / À cells exhibit an impaired Crk-Y221 phosphorylation in response to several stimuli including integrin activation, PDGF and apoptotic agents like H 2 O 2 (Ref. [137] ; R.L. Klemke and K.H. Kain unpublished data). Also, under steady-state conditions the small pool (10 -20%) of Y221-phosphorylated Crk seen in most adherent cells is completely absent in abl À / À arg À / À cells, but returns when Abl is placed back into these cells [8, 137] . This strongly implicates endogenous Abl/Arg kinases as the primary regulators of Crk phosphorylation, and points to an important housekeeping role for maintaining appropriate levels of phosphorylated Crk in cells. Future key studies will be to examine whether Crk retains the ability to translocate to the membrane and/or focal contacts in abl À / À arg À / À cells, and the mechanism of integrin-mediated Rac activation in cells without functional Abl family kinases. Also, it will be important to identify the upstream components responsible for integrin activation of Abl family kinases. In this case, Src would be a good candidate as it is activated by integrins and can in turn activate Abl and regulate cell migration [8, 110, 147] .
Coordinate regulation of cell survival and migration by CAS/Crk scaffolds
Migratory cells must coordinately activate survival mechanisms to invade the ECM and to colonize foreign tissues during embryonic development, immune surveillance, wound healing and angiogenesis. Inappropriate regulation of these processes contributes to unwanted survival of metastatic cancer cells, autoimmune disease and developmental abnormalities. Micrometastases are a particular problem because these cells have turned on migratory pathways that allow them to leave the primary tumor and travel to foreign sites, where they can lie dormant for several years avoiding apoptotic programs [148, 149] . Current evidence indicates that adhesive proteins present in the ECM not only provide migratory substrates, but also coordinately induce survival signals that allow these cells to invade and colonize new areas in the body. On the other hand, migratory cells that fail to recognize or remodel the ECM, or stray from the proper ECM path, are eliminated through activation of apoptotic mechanisms, as is the case with neural crest cell migration [150] .
Recently, integrin-mediated signals involving Abl family kinases and CAS/Crk coupling have emerged as potential regulators of both motility and apoptotic programs in normal and transformed cells [62, 137, 151] . Increased assembly of CAS/Crk complexes in cells has been shown to induce cell invasion in a collagen-rich matrix, and also protect these cells from apoptosis [5] . Furthermore, human pancreatic carcinoma cells selected for increased metastasis in animals showed decreased Crk-Y221 phosphorylation, increased CAS/Crk coupling, and increased survival in response to a collagen matrix, when compared to their noninvasive counterpart [5, 137] . Not surprisingly then, it was found that inactivation of Abl kinase facilitated increased CAS/Crk coupling and promoted increased migration and protection from apoptosis. In contrast, disassembly of CAS/Crk complexes in cells through Abl activation or expression of mutant forms of these proteins that disrupt CAS/Crk coupling caused cells to stop migrating and commit suicide [137] . Although the mechanism is not known, both the migration and survival responses required Rac activity, suggesting a close connection to the actin cytoskeleton and focal adhesion formation [5, 137] . It is likely that uncoupling of Crk from CAS disrupts normal survival signals that emanate from focal adhesions and the cytoskeleton. Interestingly, withdrawal of growth factors from cells disrupts FAK signaling which leads to apoptosis, and this response involves signaling through CAS [152] . Additionally, several reports have shown Abl-mediated apoptosis following exposure of cells to DNA-damaging agents and oxidative stress [137, 153, 154] , and these apoptotic agents also strongly promote Crk-Y221 phosphorylation and disruption of CAS/Crk signaling in cells, suggesting a role for the Abl/Cas/Crk pathway in this death response (Ref. [137] ; R.L. Klemke and D. Chodniewicz unpublished data). Furthermore, FAK, CAS and c-Abl are cleaved by caspases in apoptotic cells, providing direct evidence for cross-talk between these cytoskeletal-associated signals and the apoptotic machinery of the cell. Although previous work showed that Abl regulation of Crk in apoptotic cells occurs exclusively in the cytoplasm and not in the nucleus [137] , there is accumulating evidence that Crk can localize to the nucleus, where it promotes apoptosis through the Cdc2/cyclin B inhibitor, Wee1 [62] . Interestingly, Crk has been found to contain a nuclear exclusion sequence (NES) and to bind the nuclear export factor Crm1/exportin via its SH3(2) domain, and expression of a mutant Crk protein deficient in Crm1 binding promotes apoptosis of HEK 293 cells [62] .
While it is becoming clear that integrin-mediated signals control both processes, it is not yet understood how motility signals control the cell's decision to survive or commit suicide. Where and when these signals are activated within the cell is likely to play an important role in this decision making process. For example, the duration of Abl activation appears to serve a 'rheostat-like' function that carefully balances the level of CAS/Crk coupling, which then instructs the cell to either migrate or enter apoptosis. Thus, in spreading and migratory cells where integrin adhesions are being turned over, Abl activation is transient, whereas in apoptotic cells, Abl activity is generally elevated and sustained for extended periods of time [137, 142, 153] . The controlled, transient Abl activity is likely to be important for fine-tuning the dynamics of integrin adhesion and cytoskeletal rearrangement during cell migration. Conversely, sustained Abl activity causes a persistent uncoupling of CAS/Crk complexes and the cessation of survival signals that emanate from the cytoskeleton [8, 137] . This and the fact that Abl can disrupt nuclear and mitochondrial function to induce apoptosis could serve as a sensitive and potent 'apoptotic switch' to eliminate aberrant cells. If the 'rheostat' shifts too much to one side, then too little Abl activity may cause aberrant cell migration and resistance to apoptotic control, while too much Abl activity may cause cessation of movement and suicide.
CAS/Crk signaling in cancer and disease
If the endogenous role of integrin-mediated Abl activation is to down-regulate CAS/Crk coupling as a mechanism to suppress cell migration and survival, why then do constitutively activated forms of oncogenic Bcr-Abl transform lymphoid cells leading to CML [155] ? Typically, the initial cellular response to activation of an oncogene or aberrant activation of an unscheduled motility response is to commit suicide. In rare events, a few cells avoid these normal checkpoints and become transformed leading to tumor formation and metastasis. Also, leukemic cells that reside in the vasculature are not subjected to normal integrin control pathways, but rather have activated a cascade of signaling pathways involved in differentiation, proliferation and suppression of apoptosis. Interestingly, Bcr-Abl appears to preferentially interact with CrkL over c-CrkII suggesting that Bcr-Abl may have bypassed this normal checkpoint [156, 157] . Amplification of c-CrkII in epithelial and fibroblast cells suppresses apoptotic mechanisms and may itself be transforming as recently reported [5, 158] . While originally only CrkI had been reported to have oncogenic potential as overexpression of CrkI readily formed tumors in nude mice [159] , recently it has been demonstrated that amplification of the Crk protein in NIH 3T3 cells can induce cellular transformation through activation of RhoA and the serum response factor (SRF) [158] . Additionally, the levels of the CrkI oncoprotein and phosphorylated CrkII were significantly increased in clinically aggressive lung adenocarcinomas [11] . Thus, there is now evidence that all Crk family members are capable of transforming cells and are direct targets of several oncogenes, which strongly implicates these adaptor proteins in cancer [12, 13, 137, 158] . Clearly, additional work is needed to clarify how Abl and Crk/CrkL contribute to human cancer as well as where these events operate in cancer progression.
CAS is also likely to contribute to cancer as fibroblast cells isolated from CAS knockout animals cannot be transformed by Src and show a variety of genetic alterations due to the loss of CAS [160] . CAS has also been shown to contribute to antiestrogen-resistant breast cancer in humans [161] , and amplification of ErbB2 facilitates increased CAS/ Crk coupling in several breast adenocarcinoma cell lines [162] . Furthermore, human pancreatic cells that exhibit increased metastasis in animals show increased CAS/Crk complexes that result from decreased Crk phosphorylation at tyrosine 221. Clearly, work is warranted to determine whether alterations in CAS/Crk signals are prevalent in human cancers and whether these signals contribute to a more aggressive phenotype leading to poor patient prognosis. Finally, CAS/Crk coupling has been linked to other biological processes, including integrin-mediated adenovirus internalization [84] , infection of epithelial cells by Yersinia pseudotuberculosis which causes gastroenteritis [163] , and myogenesis [164] .
Conclusions and future perspectives
In this review, we focused on the CAS/Crk-signaling module and its role as a switch that couples integrins to the migration and survival machineries of the cell. FAK and/or Src tyrosine kinases appear to serve as positive amplifiers of CAS/Crk assembly through phosphorylation of multiple tyrosine residues in the substrate domain of CAS. Signal amplification then results from the docking of multiple Crk molecules to CAS, which in turn leads to the recruitment of various effectors that couple the scaffold to the actin cytoskeleton of the cell. Although our understanding is incomplete, current evidence indicates that the plasma membrane and focal adhesions are important sites where CAS/Crk assembles to modulate cell migration and survival. The level of CAS/Crk coupling in the cell is carefully controlled by a negative feedback mechanism that involves Abl-mediated Crk-Y221 phosphorylation and dephosphorylation by PTP-1B. Equally important in this response is regulated dephosphorylation of the substrate domain of CAS via PTP-PEST, which is necessary for modulation of Crk binding, and thus, proper organization of the cytoskeleton and cell migration.
In summary, while adhesive proteins in the extracellular environment serve as a supporting network for tissues, they also provide critical spatial and temporal information to maintain normal homeostasis in the body through regulation of cell polarity, differentiation, proliferation and motility. Research over the last decade has shown that integrins play a key role in relaying information from the extracellular environment to the interior of the cell. This occurs through complex signaling pathways that involve switches, timers, oscillators and sensitive rheostats. As with other signaling receptors, the integrin field is now faced with understanding how these complex signaling networks are organized to produce specific biological responses. This is no easy challenge given the fact that many information modules appear to cross-talk with other signaling networks to control numerous cell processes, as is the case with cooperative control of apoptosis and migration by CAS/Crk coupling. A complete understanding of how these signaling modules control specific responses will be gained when we understand precisely how they are organized in time and space, followed by application of realistic computer modeling of probable interactions and large scale bioinformatics. Only when this is achieved will we be able to systematically map signaling cascades and assign with confidence a given signaling network, with all of its regulatory components (positive and negative switches, amplifiers, modulators, etc.), to a specific biological outcome. Development of FRET-technology that reports specific protein/protein interactions as well as specific changes in protein conformation due to activation/inactivation processes promises to provide crucial information on complex signaling events in time and space. This along with ever-increasing repertoire of antibodies that detect specific posttranslational protein modifications and structural conformations that reflect activity states will undoubtedly provide a more complete understanding of how complex signaling networks like the CAS/ Crk scaffold are assembled and partitioned into microdomains within the cell.
